Primary spinal oligoastrocytoma: A case report

Surgical Neurology

Volumn 61, Issue 1, 2004, Pages 77-81

  Shimizu, Tatsuya ^a,c   Saito, Nobuhito ^a   Aihara, Masanori ^a   Kurihara, Hideyuki ^a   Nakazato, Yoichi ^a   Ueki, Keisuke ^b   Sasaki, Tomio ^a  

^a GUNMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

FDG PET; Genetic analysis; Oligoastrocytoma; Spine

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PROCARBAZINE; RANIMUSTINE; VINCRISTINE;

ARTICLE; ASTROCYTOMA; CANCER SURGERY; CASE REPORT; CHROMOSOME 10Q; CHROMOSOME 19Q; CHROMOSOME 1P; CONCENTRATION RESPONSE; FEMALE; GENETIC ANALYSIS; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LABORATORY TEST; LAMINOPLASTY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PHOTON EMISSION TOMOGRAPHY; PRIMARY SPINAL CORD OLIGOASTROCYTOMA; SCHOOL CHILD; SCOLIOSIS; SPINAL CORD LESION; SPINAL CORD TUMOR; SYRINGOBULBIA; SYRINGOMYELIA; TISSUE SECTION;

EID: 0346096601     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(03)00397-5     Document Type: Article

References (21)

1. Carincross J.G., Ueki K., Zlatescu M.C., et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 90:1998;1473-1479.
2. Coons S.W., Johnson P.C., Pearl D.K. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery. 41:1997;878-884.
3. Dehghani F., Schachenmayr W., Laun A., Korf H.W. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas a study of 89 cases . Acta Neuropathol (Berl). 95:1998;493-504.
4. Gilmer-Hill H.S., Ellis W.G., Imbesi S.G., Boggan J.E. Spinal oligodendroglioma with gliomatosis in a child. J Neurosurg. 92:2000;109-113. (Spine 1).
5. Heegaard S., Sommer H.M., Broholm H., Broendstrup O. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer. 76:1995;1809-1813.
6. Kamoto Y., Sadato N., Yonekura Y., et al. Visualization of the cervical spinal cord with FDG and high-resolution PET. J Comput Assist Tomogr. 22:1998;487-491.
7. Kaschten B., Stevenaert A., Sadzot B., et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med. 39:1998;778-785.
8. Kim L., Hochberg F.H., Thornton A.F., et al. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg. 85:1996;602-607.
9. Michalowska M., Jedrzejczak J., Krolicki L., Kroh H., Koszewski W. [Anaplastic oligoastrocytoma of spinal cord diagnostic difficulties. Case report] . Neurol Neurochir Pol. 34:2000;995-1004.
10. Minehan K.J., Shaw E.G., Scheithauer B.W., Davis D.L., Onofrio B.M. Spinal cord astrocyotma pathological and treatment considerations . J Neurosurg. 83:1995;590-595.
11. Olson J.D., Riedel E., DeAngelis L.M. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 54:2000;1442-1448.
12. Piepmeier J., Christopher S., Spencer D., et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery. 38:1996;872-878.
13. Shaw E.G., Scheithauer B.W., O'Fallon J.R. Supratentorial gliomas a comparative study by grade and histologic type . J Neurooncol. 31:1997;273-278.
14. Shaw E.G., Scheithauer B.W., O'Fallon J.R., Davis D.H. Mixed oligoastrocytomas a survival and prognostic factor analysis . Neurosurgery. 34:1994;577-578.
15. Shimada Y., Kubo O., Tajika Y., Hiyama H., Atuji S., Takakura K. Clinicopathological study of mixed oligoastrocytoma. Nagai M. Brain Tumor Research and Therapy. 1997;51-60 Springer-Verlag, Tokyo.
16. Smith J.S., Perry A., Borell T.J., et al. Alteration of chromosome armes 1p and 19q as predictors of survival in oligodendrogliomas, Astrocytomas, and mixed oligoastrocytomas. J Clin Oncol. 18:2000;636-645.
17. 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride. Neuroradiology. 40:1998;210-215.
18. Ueki K., Nishikawa R., Nakazato Y., et al. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res. 8:2002;196-201.
19. Ushida T., Sonobe H., Mizobuchi H., Toda M., Tani T., Yamamoto H. Oligodendroglioma of the "widespread" type in the spinal cord. Childs Nerv Syst. 14:1998;751-755.
20. Van Velthoven V., Calliauw L., Caemaert J. Intramedullary spread of a cerebral oligodendroglioma. Surg Neurol. 30:1988;476-481.
21. Wilmshurst J.M., Barrington S.F., Pritchard D., et al. Positron emission tomography in imaging spinal cord tumors. J Child Neurol. 15:2000;465-472.